OpenVSafe by OpenVAERS
Search V-safe

F6Z-33077-14470

3 vaccinations 6 coded responses 36 check-ins 6 free-text entries 1 call case
Sex
Male
Age at first dose
66+
ZIP prefix
992 / WA
Registered
2021-01-27
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-27
    Registered in v-safe
  2. 2021-01-27
    Dose 1 — Moderna
  3. 2021-01-27
    Survey response — day 0, dose 1
    MedDRA: Headache — Feeling: Good · Headache
    Free text: Slight/mild headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-03
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-02-10
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-17
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-02-24
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-02-27
    Dose 2 — Moderna
  15. 2021-02-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-03-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-03-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-03-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-03-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-03-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-03-06
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-03-13
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-20
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-27
    Survey response — day 28, dose 2
    MedDRA: Blindness, Diplopia, Emergency care — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: I dont believe it was from sny sise effect but should note had E.R. visit possible stroke, as my eyes had visual loss and double vision
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-03-27
    Report sent to call center — day 28, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  26. 2021-04-03
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-04-10
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-05-31
    Survey response — 3 months, dose 2
    MedDRA: Antiphospholipid syndrome, Eye disorder — Feeling: Good · Be unable to do your normal daily activities
    Free text: Diagnosed with, Antiphospholipid Syndrome after eye stroke.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-08-28
    Survey response — 6 months, dose 2
    MedDRA: Antiphospholipid syndrome, Transient ischaemic attack — Feeling: Good · Be unable to do your normal daily activities
    Free text: Brain and Ocular TIA, diag with antiphospholipid syndrome causes Blood clots injection? Who knows .
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  30. 2021-10-21
    Dose 3 — Moderna
  31. 2021-10-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  32. 2021-10-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  33. 2021-10-28
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-11-02
  35. 2021-11-04
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-11-05
  37. 2021-11-11
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-18
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-11-25
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-12-02
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-01-20
    Survey response — 3 months, dose 3
    MedDRA: Antiphospholipid syndrome — Feeling: Good
    Free text: Antiphospholipid Syndrome
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-04-21
    Survey response — 6 months, dose 3
    MedDRA: Antiphospholipid syndrome, SARS-CoV-2 test positive, Systemic lupus erythematosus — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Antiphospholipid Syndrome, Lupus And just tested positive Covid on 4/20/22
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-10-21
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-27Moderna
22021-02-27Moderna
32021-10-21Moderna No

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — day 0, dose 1

2021-01-27

Systemic reaction (other): Slight/mild headache

Release 6 — day 28, dose 2

2021-03-27

Symptoms: I dont believe it was from sny sise effect but should note had E.R. visit possible stroke, as my eyes had visual loss and double vision

Release 8 — 3 months, dose 2

2021-05-31

Symptoms: Diagnosed with, Antiphospholipid Syndrome after eye stroke.

Release 9 — 6 months, dose 2

2021-08-28

Symptoms: Brain and Ocular TIA, diag with antiphospholipid syndrome causes Blood clots injection? Who knows .

Release 10 — 3 months, dose 3

2022-01-20

Symptoms: Antiphospholipid Syndrome

Release 11 — 6 months, dose 3

2022-04-21

Symptoms: Antiphospholipid Syndrome, Lupus And just tested positive Covid on 4/20/22

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAntiphospholipid syndrome ✓ ✓ ✓
SDBlindness ✓ ✓ ✓
SDDiplopia ✓ ✓ ✓
SDEmergency care ✓ ✓ ✓
SDEye disorder ✓ ✓ ✓
SDSARS-CoV-2 test positive · · ✓
SDSystemic lupus erythematosus · · ✓
SDTransient ischaemic attack ✓ · ✓
SROHeadache ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release